COCP vs OXY · rev $105.0K vs rev $21.59B
Cocrystal Pharma Inc (COCP) versus OXY (OXY) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
OXY (OXY) common stock.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported OXY revenue for 2025-12-31 was $21.59B. Net income was $2.37B. Revenue was down 19.2% from 2024-12-31 to 2025-12-31. OXY currently screens at market cap $0.
COCP currently screens at market cap $13.3M. OXY currently screens at market cap $0.
Not investment advice. Open the COCP and OXY stock pages for the full models.
Not investment advice.